NCT00651937 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 39
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 80
- units
- Participants
- groups
- description
- Patients undergoing ASCT for MM who were ≥60 years old or had AL amyloidosis were randomized to receive either a standard (4-6×106 cells/kg) of CD34+ cells after melphalan 200 mg/m2.
- id
- BG000
- title
- Standard Dose Stem Cell Group
- description
- Patients undergoing ASCT for MM who were ≥60 years old or had AL amyloidosis were randomized to receive high dose (10-15×106 cells/kg) of CD34+ cells after melphalan 200 mg/m2.
- id
- BG001
- title
- High Dose Stem Cell Group
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 42
- upper Limit
- 79
- value
- 64
- group Id
- BG001
- lower Limit
- 37
- upper Limit
- 75
- value
- 65
- group Id
- BG002
- lower Limit
- 37
- upper Limit
- 79
- value
- 65
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 25
- title
- Female
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 55
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 39
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 80
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 39
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 80
- units
- Participants
- groups
- description
- Patients undergoing ASCT for MM who were ≥60 years old or had AL amyloidosis were randomized to receive either a standard (4-6×106 cells/kg) of CD34+ cells after melphalan 200 mg/m2.
- id
- BG000
- title
- Standard Dose Stem Cell Group
- description
- Patients undergoing ASCT for MM who were ≥60 years old or had AL amyloidosis were randomized to receive high dose (10-15×106 cells/kg) of CD34+ cells after melphalan 200 mg/m2.
- id
- BG001
- title
- High Dose Stem Cell Group
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 42
- upper Limit
- 79
- value
- 64
- group Id
- BG001
- lower Limit
- 37
- upper Limit
- 75
- value
- 65
- group Id
- BG002
- lower Limit
- 37
- upper Limit
- 79
- value
- 65
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 25
- title
- Female
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 55
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 39
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 80
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle